Publications of U. Reichl

Vester, D., Rapp, E., Kluge, S., Genzel, Y., & Reichl, U. (2010)Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von ProduktionszelllinienIn: Chemie Ingenieur Technik, 1496doi: 10.1002/cite.201050197.

Öncül, A., Kalmbach, A., Genzel, Y., Reichl, U., & Thevenin, D. (2009)Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-BioreaktorenIn: Chemie-Ingenieur-Technik, 1241 doi: 10.1002/cite.200950096.

Sidorenko, Y., Dauner, M., Genzel, Y., & Reichl, U. (2006)Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture MediaIn: Metabolic Engineering VI: Program, 102.

Sidorenko, Y., Schulze-Horsel, J., Voigt, A., Reichl, U., & Kienle, A. (2006)Stochastic Population Balance Modeling of Influenza Virus replication in a Vaccine Production ProcessIn: Conference Proceedings / AIChE annual meeting 2006, 622f.

Sidorenko, Y. & Reichl, U. (2004)A Mathematical Model for the Replication of Influenza A VirusIn: BioPerspective 2004: mit 22. DECHEMA-Jahrestagung der Biotechnologen: Kurzfassungen, 82.

Sidorenko, Y. & Reichl, U. (2004)A Model for the Influenza Virus Live-Cycle in a Single CellIn: ICSB: 5th International Congress on Systems Biology: Book of abstracts, 382.

Möhler, L., Flockerzi, D., & Reichl, U. (2002)Mathematical Model of Virus Replication in Animal CellsIn: Chemie Ingenieur Technik, 661–662doi: 10.1002/1522-2640(200205)74:5<661::AID-CITE1111661>3.0.CO;2-W.

Trotha, R., Reichl, U., Koenig, W., & Koenig, B. (2002)Validation of a T-RFLP Technique for the Precise Qualitative and Quantitative Characterization of Microbioal Communities by Using an Automated High Throughput Multi-Capillary Electrophoresis DeviceIn: Abstracts of the General Meeting of the American Society for Microbiology, 323.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Kershaw, O., Volckmar, J., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo EfficacyPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Volckmar, J., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacyPresented at: 9^th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.

Zinnecker, T. M., Wicke, E., Göbel, S., Reichl, U., & Genzel, Y.Exploring High Cell Density Perfusion Cultivations for Influenza Virus Production using TFDF TechnologyPresented at: Himmelfahrtstagung on Bioprocess Engineering 2025 Bremen (Germany), May 26, 2025.

Zuniga-Banuelos, F. J., Lemke, G., Hoffmann, M., Reichl, U., & Rapp, E.Expanding Glycoproteomics: Including N-Glycopeptides Bearing Glucuronidated, O-Acetylated or Sulfated N-Glycans in the Analysis of Human Serum Proteins such as Immunoglobulin APresented at: GlycoBioTec 2025Berlin (Germany), February 9, 2025.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: 6^th MECP (Multistep Enzyme Catalyzed Processes) CongressVienna (Austria), April 14, 2024.

Genzel, Y., Göbel, S., & Reichl, U.Shaking to very high cell densities - perfusion for virus productionPresented at: Kuhner Large Scale MeetingGirona (Spain), May 29, 2024.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yieldPresented at: 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI)Rio de Janeiro (Brazil), May 7, 2024.

Pelz, L., Rüdiger, D., Hein, M., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered defective interfering particles of influenza A virus for antiviral treatmentPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systemsPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissuesPresented at: KSMB-SMB 2024Seoul (South Korea), June 29, 2024.

Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.